Search
Search Results
-
Prognostic factors for gastric cancer patients aged ≥ 85 years
BackgroundAs gastric cancer patients aged ≥ 85 years have a short life expectancy and often die from other diseases such as pneumonia, indications...
-
Diagnostic and Prognostic Implications of Cancer Stem Cell Transcription Factors
Cancer stem cells (CSCs) are a subpopulation of malignant cells with self-renewing capacity, hence being vital in the areas of tumour initiation and...
-
Prognostic factors for falls in Parkinson’s disease: a systematic review
BackgroundFalls represent a critical concern in Parkinson’s disease (PD), contributing to increased morbidity and reduced quality of life.
...
-
Conditional survival in multiple myeloma and impact of prognostic factors over time
Overall survival estimates from diagnosis are valuable for guiding treatment, but do not consider the years already survived. Conditional survival...
-
Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis
BackgroundColorectal cancer (CRC) is the 3rd most common malignancy with the liver being the most common site of metastases. The recurrence rate of...
-
Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer
BackgroundEGFR inhibitor and immunotherapy have been approved for adjuvant treatment in resectable non-small cell lung cancer (NSCLC). Limited...
-
Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation
BackgroundSevere pneumonia is one of the most important causes of mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT)....
-
Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors
Combination chemoimmunotherapy (CIT) consisting of anti-CD20 has improved the progression-free survival (PFS) and overall survival (OS) of patients...
-
Clinical characteristics and prognostic risk factors of candidemia in non-neutropenic patients: a retrospective cohort study
This study aimed to determine the clinical characteristics and the prognostic risk factors in non-neutropenic patients with candidemia. Data were...
-
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
BackgroundReal-world data on treatment patterns/outcomes for metastatic pancreatic cancer (mPAC) are limited. This study aims to assess real-world...
-
Prognostic risk factors of serous ovarian carcinoma based on mesenchymal stem cell phenotype and guidance for therapeutic efficacy
BackgroundEpithelial ovarian cancer is the leading cause of death from gynecologic cancer, in which serous ovarian carcinoma (SOC) is the most common...
-
Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer
BackgroundAngiogenesis is crucial for tumor development, progression, and metastasizing. The most important regulator of angiogenesis is the vascular...
-
Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants
BackgroundThe SARS-CoV-2 Omicron variant has replaced the previously dominant Delta variant because of high transmissibility. However, studies on the...
-
Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review
AimsAnal cancer is primarily treated using concurrent chemoradiotherapy (CRT), with conformal techniques such as intensity modulated radiotherapy...
-
Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
BackgroundTo investigate the prognostic factors affecting long-term survival in locally advanced cervical cancer (LACC) patients treated with...
-
Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinoma
BackgroundHepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, with a high mortality rate and poor prognosis. Mutated or...
-
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials
BackgroundPatient selection is key in Phase I studies, and prognosis can be difficult to estimate in heavily pre-treated patients. Previous...
-
Diagnostic-Prognostic Biomarkers and Their Clinical Implication in Breast Cancer
Breast cancer (BC) is a complex disease that continues to affect global cancer fatalities with its high incidence rate. Hence, BC requires...
-
Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning
Breast cancer remains the most prevalent cancer in women. To date, its underlying molecular mechanisms have not been fully uncovered. The...
-
Survival outcomes and prognostic factors for first-line abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer
PurposeTo investigate the survival outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients receiving first-line novel androgen...
